Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synlogic and Caldera sign merger agreement
Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.
Crohn's Disease (Regional Enteritis)
-
30 Jul 2026
-
20 Jun 2022
FDA approves AbbVie’s Skyrizi to treat Crohn’s Disease in adults
The US Food and Drug Administration (FDA) has approved AbbVie’s approved Skyrizi (risankizumab-rzaa) for the treatment of Crohn's disease (CD) in adults.